Return on investment (ROI) has long been the holy grail of chronic condition management programs. But as cardiometabolic care needs grow more complex—and high-cost therapies like GLP-1s surge in demand—loose, interpretive, or convenient definitions of ROI simply aren’t enough.
It’s time to redefine ROI for what it really is: the ability to deliver clinical outcomes, cost efficiency, and scalable, sustainable impact across populations.
The Problem with Traditional Approaches
Most point solutions promise ROI in the form of engagement metrics, app usage, or weight loss milestones. But these outcomes:
- Don’t account for comorbidities
- Don’t reflect medication cost or medical utilization
- Don’t scale across diverse populations
- And perhaps most importantly—they don’t last.
Why Integrated Care Yields Higher, Truer ROI
At Cecelia Health, we deliver care through a virtual specialty medical practice. That means our ROI is built on coordinated care informed by real-world evidence and clinical insights—not app check-ins or self-guided content.
Our approach is designed to influence multiple cost drivers across healthcare spend through:
- Claims & Clinical Data Insight: Enables precision segmentation and resource optimization
- Clinical Support: Clinician-guided interventions across clinical, nutrition, lifestyle, and behavior change
- Medication Management: Optimal outcomes through appropriate dosage, titration; addresses side effects, increases adherence, and reduces waste
- Pharmacy Cost Control: Adherence-driven outcomes; Rx cost savings across populations for GLP-1s for weight loss
- High-Touch Engagement: Increases short- and long-term efficacy and satisfaction
Proof in the Data: ROI from the Cecelia Health Approach to Integrated Cardiometabolic Care
Our partners realize up to 4.0x ROI — this isn’t surface-level savings. It’s deep, sustained clinical and financial impact.
What Health Plans Should Look for in ROI Today
- Does your solution influence both medical cost and pharmacy spend?
- Is care coordinated across a care team to address comorbid conditions?
- Can your solution adapt to expanding indications of high-cost therapy usage, like GLP-1s?
- Is there evidence of long-term member engagement and satisfaction?
- Does your solution support benefits integration and system-wide efficiencies?
If the answer isn’t “yes” to all five—you’re not maximizing ROI.
The Bottom Line
True ROI in cardiometabolic care isn’t about app logins or one-time weight loss. It’s about sustained outcomes, whole-person health, and population-level cost savings.
That’s why Cecelia Health doesn’t just offer a tool. We offer clinically-led, integrated, interdisciplinary care that flexes for your population’s needs.